Pfizer and German partner BioNTech SE are the first drug makers to release successful data from a large-scale clinical trial of a coronavirus vaccine. Photo: Reuters
Pfizer coronavirus vaccine more than 90 per cent effective, US drug maker says
- Pfizer and German partner BioNTech have a US$1.95 billion contract with the US government to deliver 100 million vaccine doses beginning this year
- Questions remain, including how long the vaccine will provide protection, but Pfizer expects to produce up to 1.3 billion doses in 2021
Pfizer and German partner BioNTech SE are the first drug makers to release successful data from a large-scale clinical trial of a coronavirus vaccine. Photo: Reuters
